誉衡药业 (002437.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(誉衡药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) -14.0078.0080.0078.0077.0080.0075.0076.00
 单季度销售净利率(%) -18.0032.001.003.00-47.001.003.00-
 单季度净资产收益率ROE(%) -6.0011.00-1.00-18.00-1.00-
 单季度总资产净利率ROA(%) -3.006.00-1.00-8.00-1.00-
单季度财务摘要:
 单季度营业总收入(元) 574,030,802.00619,345,304.00751,494,230.00681,168,971.00692,888,356.00815,488,138.00825,356,679.00774,211,987.00
 单季度营业总成本(元) 552,257,245.00597,047,969.00703,614,746.00636,373,987.00740,362,988.00786,910,424.00784,812,368.00733,867,371.00
 单季度营业收入(元) 574,030,802.00619,345,304.00751,494,230.00681,168,971.00692,888,356.00815,488,138.00825,356,679.00774,211,987.00
 单季度营业利润(元) -85,363,083.00209,038,314.0019,155,178.0032,216,203.00-338,637,134.0011,636,927.0041,468,076.0015,446,773.00
 单季度利润总额(元) -83,419,704.00208,817,033.0019,367,355.0032,013,465.00-337,477,094.0011,690,915.0041,400,801.0014,706,825.00
 单季度净利润(元) -102,360,437.00198,778,029.0010,412,604.0021,870,445.00-326,823,186.005,508,431.0028,750,966.003,046,070.00
 单季度归属母公司股东的净利润(元) -103,289,363.00195,374,523.008,190,429.0020,058,599.00-321,433,659.003,234,303.0025,872,260.00998,263.00
 单季度经营活动产生的现金流量(元) -32,965,260.00104,669,796.00118,771,382.0083,699,367.00-6,502,266.00116,543,581.0094,753,096.0056,821,197.00
 单季度投资活动产生的现金流量(元) -13,380,895.0065,477,898.0017,135,498.0025,147,232.0010,452,844.00-45,347,822.00-71,981,847.00-117,006,134.00
 单季度筹资活动产生的现金流量(元) -178,333,623.00-208,889,873.00-400,677,121.00-101,258,940.00-132,124,563.00-28,764,503.00-23,935,174.00-27,724,573.00
 单季度现金及现金等价物净增加(元) -225,535,365.00-39,088,774.00-261,808,770.006,815,714.00-129,716,032.0049,196,065.006,069,372.00-88,440,630.00

前瞻产业研究院